Prediction of Amyloid Positivity in Mild Cognitive Impairment Using Fully Automated Brain Segmentation Software

• Published in: Neuropsychiatric disease and treatment Vol. 16; pp. 1745 - 1754
• Main Authors: Kang, Koung Mi, Sohn, Chul-Ho, Byun, Min Soo, Lee, Jun Ho, Yi, Dahyun, Lee, Younghwa, Lee, Jun-Young, Kim, Yu Kyeong, Sohn, Bo Kyung, Yoo, Roh-Eul, Yun, Tae Jin, Choi, Seung Hong, Kim, Ji-Hoon, Lee, Dong Young
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 2020; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: Age; Aging; Alzheimer's disease; Amyloid; Automation; Brain research; brain segmentation; Cognitive ability; cognitive impairment; Computer programs; Dementia; Dementia disorders; Development and progression; FDA approval; Hippocampus; Magnetic resonance imaging; Medical research; Memory; Neurodegenerative diseases; Original Research; Positron emission tomography; Predictions; Segmentation; Software; Statistical analysis; Substantia grisea; Technology application; South Korea; Pennsylvania; United States > US; magnetic resonance imaging; cognitive impairment; amyloid; brain segmentation
• ISSN: 1176-6328; 1178-2021; 1178-2021
• DOI: 10.2147/NDT.S252293

To assess the predictive ability of regional volume information provided by fully automated brain segmentation software for cerebral amyloid positivity in mild cognitive impairment (MCI). This study included 130 subjects with amnestic MCI who participated in the Korean brain aging study of early diagnosis and prediction of Alzheimer's disease, an ongoing prospective cohort. All participants underwent comprehensive clinical assessment as well as C-labeled Pittsburgh compound PET/MRI scans. The predictive ability of volumetric results provided by automated brain segmentation software was evaluated using binary logistic regression and receiver operating characteristic curve analysis. Subjects were divided into two groups: one with Aβ deposition (58 subjects) and one without Aβ deposition (72 subjects). Among the varied volumetric information provided, the hippocampal volume percentage of intracranial volume (%HC/ICV), normative percentiles of hippocampal volume (HC ), and gray matter volume were associated with amyloid-β (Aβ) positivity (all < 0.01). Multivariate analyses revealed that both %HC/ICV and HC were independent significant predictors of Aβ positivity (all < 0.001). In addition, prediction scores derived from %HC/ICV with age and HC showed moderate accuracy in predicting Aβ positivity in MCI subjects (the areas under the curve: 0.739 and 0.723, respectively). Relative hippocampal volume measures provided by automated brain segmentation software can be useful for screening cerebral Aβ positivity in clinical practice for patients with amnestic MCI. The information may also help clinicians interpret structural MRI to predict outcomes and determine early intervention for delaying the progression to Alzheimer's disease dementia.